查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612180

動物用藥品市場：按類型、給藥途徑、應用和最終用戶分類 - 全球預測 2025-2030

Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Route of Administration (Injectable, Oral, Topical), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物用藥品市值為580.7億美元，預計2024年將達到629.9億美元，複合年成長率為8.61%，到2030年將達到1035.7億美元。

動物用藥品市場包括專門為動物（包括牲畜、寵物和野生動物）的健康和福祉而設計的產品。這個市場包括疫苗、抗生素、抗寄生蟲藥物和藥物飼料添加劑等多種產品。對畜牧產品的需求不斷成長、寵物飼養量的增加以及控制通用感染疾病的需要加劇了對動物用藥品的需求。主要用途包括動物疾病預防、治療和促進生長，對食品安全、公共衛生和消費者安全有直接影響。最終使用領域包括獸醫醫院、農場、寵物醫院和動物研究所。成長要素包括畜牧業生產集約化、寵物旅行快速成長、技術進步、動物疾病發生率增加。機會包括新型高效藥物的開發、藥物輸送系統的創新以及對天然和有機畜牧產品日益成長的偏好。隨著消費者需求傾向於永續和健康意識的解決方案，鼓勵公司專注於生物製藥和食品。挑戰包括嚴格的監管標準、不斷上升的研發成本以及抗藥性菌株的出現，這可能會阻礙市場擴張。此外，有關動物福利和抗生素過度使用的倫理問題也構成了主要障礙。需要創新的領域包括開發益生菌和益生元等抗生素替代品、增強疫苗功效以及利用資料分析進行個人化動物保健。專注於獸醫遠端醫療和人工智慧疾病診斷工具等數位醫療解決方案也可以推動業務成長。市場競爭激烈，監管壓力不斷變化，需要不斷創新來應對不斷變化的獸醫健康挑戰，而且市場很複雜，需要戰略靈活性和持續的研究投資。

主要市場統計
基準年[2023] 580.7億美元
預測年份 [2024] 629.9億美元
預測年份 [2030] 1035.7億美元
複合年成長率（%） 8.61%

市場動態：揭示快速發展的動物用藥品市場的關鍵市場洞察

供需的動態交互作用正在改變動物用藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於通用感染疾病和慢性病的增加，寵物擁有量增加
    • 牲畜顯著增加
    • 政府強制管理藥物和疫苗接種
  • 市場限制因素
    • 由於寵物飼主的認知和教育有限，動物用藥品高成本
  • 市場機會
    • 對有機和天然動物用藥品的需求不斷成長
    • 針對個別動物的精準醫療日益興起
  • 市場挑戰
    • 由於畜牧農民過度使用抗生素，人們越來越擔心抗生素抗藥性

波特五力：駕馭動物用藥品市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解動物用藥品市場的外部影響

外部宏觀環境因素對動物用藥品市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解動物用藥品市場競爭狀況

動物用藥品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣動物用藥品市場供應商的績效評估

FPNV定位矩陣是評估動物用藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪動物用藥品市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物用藥品市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 寵物數量增加，通用和感染疾病增加
      • 牲畜存欄量大幅增加
      • 政府強制用藥和疫苗接種的出現
    • 抑制因素
      • 動物用藥品成本高昂，寵物飼主的認知與教育有限
    • 機會
      • 對有機和天然動物用藥品的需求不斷成長
      • 針對個別動物的精準醫療不斷湧現
    • 任務
      • 由於動物養殖場過度使用抗生素，人們越來越擔心抗生素抗藥性
  • 市場區隔分析
    • 類型：增加緊急治療所需的動物用藥品使用
    • 最終用戶：推動獸醫診所動物用藥品的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物用藥品市場：依類型

  • 疫苗
    • 惰性（殺死）
    • 修復/衰減即時
  • 動物用藥品
    • 止痛藥
    • 抗感染
    • 發炎（藥
    • 寄生劑

第7章動物用藥品市場：依管理途徑

  • 可注射的
  • 口服
  • 話題

第8章動物用藥品市場：依用途

  • 水生動物
  • 伴同性動物
  • 家畜

第9章動物用藥品市場：依最終用戶分類

  • 醫院
  • 研究所
  • 獸醫診所

第10章：美洲動物用藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太動物用藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲動物用藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zoetis 在美國推出 BoncatPregabalin口服溶液，加強貓咪護理
    • Zoetis 和 Blacksmith Medicines 合作開發新型抗生素來對抗抗藥性細菌並改善動物健康
    • 默克策略收購Elanco海鮮業務以加強其水產養殖部門
  • 戰略分析和建議

公司名單

  • Alivira Animal Health Limited
  • Aurora Pharmaceutical, Inc.
  • Bimeda Holdings PLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Neogen Corp.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Laboratories
  • Nutreco NV
  • Orion Corporation
  • Ourofino Saude Animal
  • Perrigo Company plc
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Precision Science
  • Sanofi-Aventis Groupe SA
  • Vesper Group
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-434CCDA05128

The Animal Pharmaceuticals Market was valued at USD 58.07 billion in 2023, expected to reach USD 62.99 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 103.57 billion by 2030.

The animal pharmaceuticals market encompasses products designed specifically for the health and well-being of animals, including livestock, pets, and wildlife. This market covers a range of products such as vaccines, antibiotics, antiparasitics, and medicinal feed additives. The necessity of animal pharmaceuticals is underscored by the rising demand for livestock products, increased pet ownership, and the need to manage zoonotic diseases. Key applications include disease prevention, treatment, and growth promotion in animals, which directly impacts food security, public health, and consumer safety. End-use sectors span veterinary clinics, animal farms, pet hospitals, and animal research institutes. Influencing growth factors include the intensification of livestock production, the surge in pet companionship, technological advancements, and increasing incidences of animal disease outbreaks. Opportunities emerge from the development of novel and efficient drugs, innovations in drug delivery systems, and the growing preference for natural and organic animal products. Companies are advised to focus on biopharmaceuticals and nutraceuticals, as consumer demand leans toward sustainable and health-conscious solutions. Challenges include stringent regulatory standards, high R&D costs, and the emergence of drug-resistant strains, which can inhibit market expansion. Additionally, ethical concerns regarding animal welfare and the overuse of antibiotics present significant hurdles. Areas ripe for innovation include the development of alternatives to antibiotics, such as probiotics and prebiotics, enhancing vaccine efficacy, and leveraging data analytics for personalized animal healthcare. Emphasizing digital healthcare solutions like telemedicine for animals and AI-driven disease diagnosis tools can also propel business growth. The market is competitive and dynamic, driven by regulatory pressures and the necessity for constant innovation to address evolving animal health challenges, signifying a complex landscape that necessitates strategic agility and continuous research investments.

KEY MARKET STATISTICS
Base Year [2023] USD 58.07 billion
Estimated Year [2024] USD 62.99 billion
Forecast Year [2030] USD 103.57 billion
CAGR (%) 8.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Pharmaceuticals Market

The Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
    • Significant growth experienced in livestock population
    • Emergence of government mandatory medication and vaccinations
  • Market Restraints
    • High costs of animal pharmaceuticals along with limited awareness and education among pet owners
  • Market Opportunities
    • Growing demand for organic and natural animal pharmaceuticals
    • Increasing emergence of the precision medicine tailored for individual animals
  • Market Challenges
    • Increasing concern over antibiotic resistance due to overuse in animal farms

Porter's Five Forces: A Strategic Tool for Navigating the Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Pharmaceuticals Market

A detailed market share analysis in the Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Pharmaceuticals Market

A strategic analysis of the Animal Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Aurora Pharmaceutical, Inc., Bimeda Holdings PLC, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Huvepharma, Inc., IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nippon Zenyaku Kogyo Co., Ltd., Norbrook Laboratories, Nutreco N.V., Orion Corporation, Ourofino Saude Animal, Perrigo Company plc, PetIQ, LLC, Phibro Animal Health Corporation, Precision Science, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Vaccine and Veterinary Drugs. The Vaccine is further studied across Inactivated (Killed) and Modified/ Attenuated Live. The Veterinary Drugs is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Application, market is studied across Aquatic Animals, Companion Animals, and Livestock Animals.
  • Based on End User, market is studied across Hospitals, Laboratories, and Veternary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
      • 5.1.1.2. Significant growth experienced in livestock population
      • 5.1.1.3. Emergence of government mandatory medication and vaccinations
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of animal pharmaceuticals along with limited awareness and education among pet owners
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for organic and natural animal pharmaceuticals
      • 5.1.3.2. Increasing emergence of the precision medicine tailored for individual animals
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing concern over antibiotic resistance due to overuse in animal farms
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of veterinary drugs indispensable for acute treatments
    • 5.2.2. End User: Evolving usage of the animal pharmaceuticals across the veterinary clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Pharmaceuticals Market, by Type

  • 6.1. Introduction
  • 6.2. Vaccine
    • 6.2.1. Inactivated (Killed)
    • 6.2.2. Modified/ Attenuated Live
  • 6.3. Veterinary Drugs
    • 6.3.1. Analgesics
    • 6.3.2. Anti-infectives
    • 6.3.3. Anti-inflammatory
    • 6.3.4. Parasiticides

7. Animal Pharmaceuticals Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Animal Pharmaceuticals Market, by Application

  • 8.1. Introduction
  • 8.2. Aquatic Animals
  • 8.3. Companion Animals
  • 8.4. Livestock Animals

9. Animal Pharmaceuticals Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Laboratories
  • 9.4. Veternary Clinics

10. Americas Animal Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Animal Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Animal Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Zoetis Enhances Feline Care with U.S. Launch of Bonqat Pregabalin Oral Solution
    • 13.3.2. Zoetis and Blacksmith Medicines Collaborate on Novel Antibiotics to Combat Resistant Bacteria and Enhance Animal Health
    • 13.3.3. Merck & Co. Bolsters Aquaculture Segment with Strategic Acquisition of Elanco's Aqua Business
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alivira Animal Health Limited
  • 2. Aurora Pharmaceutical, Inc.
  • 3. Bimeda Holdings PLC
  • 4. Boehringer Ingelheim International GmbH
  • 5. Ceva Sante Animale
  • 6. Dechra Pharmaceuticals PLC
  • 7. Elanco Animal Health Incorporated
  • 8. Hester Biosciences Limited
  • 9. Huvepharma, Inc.
  • 10. IDEXX Laboratories, Inc.
  • 11. Indian Immunologicals Ltd.
  • 12. Merck & Co., Inc.
  • 13. Neogen Corp.
  • 14. Nippon Zenyaku Kogyo Co., Ltd.
  • 15. Norbrook Laboratories
  • 16. Nutreco N.V.
  • 17. Orion Corporation
  • 18. Ourofino Saude Animal
  • 19. Perrigo Company plc
  • 20. PetIQ, LLC
  • 21. Phibro Animal Health Corporation
  • 22. Precision Science
  • 23. Sanofi-Aventis Groupe S.A.
  • 24. Vesper Group
  • 25. Vetoquinol S.A.
  • 26. Virbac S.A.
  • 27. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INACTIVATED (KILLED), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY MODIFIED/ ATTENUATED LIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023